TAKE quarterly results

Q1 FY27 · Apr–Jun 2026

₹ crore	Q1 FY27	Q1 FY26	Change
Revenue	30.4	0.0	—
EBITDA	−0.3	−0.8	—
EBITDA margin	−0.9%	—	—
Profit before tax	1.1	−0.9	—
Net profit	1.1	−0.9	—
EPS	₹0.07	−₹0.06	—

Every quarter

₹ crore except per share

Tap a line for its trend	Q1 FY27Jun 2026	Q4 FY26Mar 2026	Q3 FY26Dec 2025	Q2 FY26Sep 2025	Q1 FY26Jun 2025	Q4 FY25Mar 2025	Q3 FY25Dec 2024	Q2 FY25Sep 2024	Q1 FY25Jun 2024	Q4 FY24Mar 2024	Q3 FY24Dec 2023	Q2 FY24Sep 2023	Earlier quartersAlpha Plus

Expenses
	30.4	54.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	16.9	18.1	Earlier quartersEvery year the company has filed comes with Alpha Plus.
	1.3	5.2	1.5	0.0	0.0	1.7	8.5	0.0	0.0	0.1	1.1	0.1
	31.7	59.4	1.5	0.0	0.0	1.7	8.5	0.0	0.0	13.3	17.9	18.2
	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	6.0	6.0
	30.3	54.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.2	0.3	3.5	3.5	3.8
	0.0	0.0	0.0	0.2	0.2	0.2	0.7	0.5	0.5	1.2	1.3	1.4
	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.9	2.2
	0.3	0.8	0.2	0.2	0.6	1.0	2.5	1.0	1.9	20.7	6.2	6.5
	30.6	55.0	0.4	0.5	1.0	1.4	3.6	1.7	2.7	31.2	18.9	19.8
	−0.3	−0.8	−0.3	−0.3	−0.8	−1.1	−2.9	−1.2	−2.2	−15.2	1.1	1.8
	−0.3	−0.8	−0.4	−0.3	−0.8	−1.1	−2.9	−1.2	−2.2	−16.8	−0.7	−0.4
Profit
	1.1	4.4	1.1	−0.5	−0.9	0.3	4.9	−1.7	−2.7	−17.9	−1.0	−1.6
	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	−92.8	0.0	0.0
	1.1	4.4	1.1	−0.5	−0.9	0.3	4.9	−1.7	−2.7	−111	−1.0	−1.6
	0.0	0.0	0.0	0.2	0.0	0.0	0.0	−0.1	0.1	−0.4	0.9	0.0
	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	−0.1
	0.0	0.0	0.0	0.2	0.0	0.0	0.0	−0.1	0.1	−0.1	1.2	−0.1
	1.1	4.4	1.1	6.3	−0.9	−4.9	47.7	−1.6	−3.7	−111	−2.1	−1.5
	1.1	4.4	1.1	−0.6	−0.9	0.3	4.9	−1.7	−2.8	−111	−2.1	−1.5
	0.0	0.0	0.0	6.9	0.0	−5.2	42.8	0.1	−1.0	0.0	0.0	0.0
	0.0	0.0	0.0	0.1	−0.0	0.0	−0.1	0.1	−0.0	0.2	−0.0	−0.1
	1.1	4.4	1.1	6.3	−0.9	−4.8	47.5	−1.5	−3.8	−110	−2.1	−1.6
	—	—	—	6.3	−0.9	−4.9	47.7	−1.6	−3.7	−111	−2.1	−1.5
Per share
	₹0.07	₹0.29	₹0.07	₹0.43	−₹0.06	−₹0.33	₹3.26	−₹0.11	−₹0.26	−₹7.56	−₹0.15	−₹0.11
	₹0.07	₹0.29	₹0.07	₹0.43	−₹0.06	−₹0.33	₹3.26	−₹0.11	−₹0.26	−₹7.56	−₹0.15	−₹0.11
Continuing & discontinued operations
	0.0	0.0	0.0	6.9	0.0	−5.2	42.8	0.1	−1.0	0.0	0.0	0.0
	0.0	0.0	0.0	0.0	0.0	0.0	0.0	−0.0	0.0	0.0	0.0	0.0
Other comprehensive income — detail
	—	0.0	0.0	0.1	−0.0	0.0	—	—	—	—	—	—
	—	—	0.0	—	—	0.0	−0.0	0.1	−0.0	0.2	−0.0	−0.1
	—	—	—	—	—	—	0.0	0.0	0.0	0.1	−0.0	−0.0
	—	—	—	0.1	−0.0	0.0	−0.1	−0.0	0.0	0.0	−0.0	−0.0
	—	—	—	0.1	−0.9	−4.8	47.5	0.0	−3.8	0.2	−2.1	—
	—	—	—	6.3	0.0	0.0	0.0	−1.5	0.0	−110	0.0	—
Per share — as-filed variants
	₹0.07	₹0.29	₹0.07	−₹0.04	−₹0.06	₹0.02	₹0.33	−₹0.11	−₹0.19	−₹7.56	−₹0.15	−₹0.11
	₹0.07	₹0.29	₹0.07	−₹0.04	−₹0.06	₹0.02	₹0.33	−₹0.11	−₹0.19	−₹7.56	−₹0.15	−₹0.11
	₹0.00	₹0.00	₹0.00	₹0.47	₹0.00	−₹0.35	₹2.93	₹0.00	−₹0.07	₹0.00	₹0.00	₹0.00
	₹0.00	₹0.00	₹0.00	₹0.47	₹0.00	−₹0.35	₹2.93	₹0.00	−₹0.07	₹0.00	₹0.00	₹0.00
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	0.1	−0.0	—	—	—	—	—	—	—	9.0	10.9	12.1
	0.3%	−0.0%	—	—	—	—	—	—	—	67.9%	64.4%	66.8%
Adjusted (ex-exceptional items) — derived
	1.1	4.4	1.1	−0.5	−0.9	0.3	4.9	−1.7	−2.7	−17.9	−1.0	−1.6
	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	−92.8	0.0	0.0
	1.1	4.4	1.1	6.3	−0.9	−4.9	47.7	−1.6	−3.7	−17.9	−2.1	−1.5
	₹0.07	₹0.29	₹0.07	₹0.43	−₹0.06	−₹0.33	₹3.26	−₹0.11	−₹0.26	−₹1.22	−₹0.15	−₹0.11

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

TAKE₹11.06

TAKE Limited

· Pharma & Health

Annual Quarterly₹ CrorePeersVIMTALABS SUVENMcap ₹164 Cr

View

In ₹ Crore except Per Share 3 Months Ending	Q2 FY24 30/09/2023	Q3 FY24 31/12/2023	Q4 FY24 31/03/2024	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026
Revenue from Operations	18.1	16.9	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.2	30.4
Other Income	0.1	1.1	0.1	0.0	0.0	8.5	1.7	0.0	0.0	1.5	5.2	1.3
Total Income	18.2	17.9	13.3	0.0	0.0	8.5	1.7	0.0	0.0	1.5	59.4	31.7
Expenses
+ Cost of Materials Consumed	6.0	6.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
+ Purchases of Stock-in-Trade	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.2	30.3
+ Employee Benefit Expense	3.8	3.5	3.5	0.3	0.2	0.4	0.1	0.1	0.1	0.1	0.0	0.1
+ Finance Costs	1.4	1.3	1.2	0.5	0.5	0.7	0.2	0.2	0.2	0.0	0.0	0.0
+ Depreciation & Amortisation	2.2	1.9	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
+ Other Expenses	6.5	6.2	20.7	1.9	1.0	2.5	1.0	0.6	0.2	0.2	0.8	0.3
Total Expenses	19.8	18.9	31.2	2.7	1.7	3.6	1.4	1.0	0.5	0.4	55.0	30.6
EBITDA	1.8	1.1	-15.2	-2.2	-1.2	-2.9	-1.1	-0.8	-0.3	-0.3	-0.8	-0.3
EBIT	-0.4	-0.7	-16.8	-2.2	-1.2	-2.9	-1.1	-0.8	-0.3	-0.4	-0.8	-0.3
Profit
PBT before Exceptional Items	-1.6	-1.0	-17.9	-2.7	-1.7	4.9	0.3	-0.9	-0.5	1.1	4.4	1.1
+ Exceptional Items	0.0	0.0	-92.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Pretax Income	-1.6	-1.0	-110.8	-2.7	-1.7	4.9	0.3	-0.9	-0.5	1.1	4.4	1.1
+ Current Tax	0.0	0.9	-0.4	0.1	-0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0
+ Deferred Tax	-0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax Expense	-0.1	1.2	-0.1	0.1	-0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0
Net Income	-1.5	-2.1	-110.6	-3.7	-1.6	47.7	-4.9	-0.9	6.3	1.1	4.4	1.1
+ Net Income — Continuing Ops	-1.5	-2.1	-110.6	-2.8	-1.7	4.9	0.3	-0.9	-0.6	1.1	4.4	1.1
+ Net Income — Discontinued Ops	0.0	0.0	0.0	-1.0	0.1	42.8	-5.2	0.0	6.9	0.0	0.0	0.0
+ Other Comprehensive Income	-0.1	-0.0	0.2	-0.0	0.1	-0.1	0.0	-0.0	0.1	0.0	0.0	0.0
Total Comprehensive Income	-1.6	-2.1	-110.4	-3.8	-1.5	47.5	-4.8	-0.9	6.3	1.1	4.4	1.1
Net Income to Common	-1.5	-2.1	-110.6	-3.7	-1.6	47.7	-4.9	-0.9	6.3	—	—	—
Per Share
Basic EPS	-0.11	-0.15	-7.56	-0.26	-0.11	3.26	-0.33	-0.06	0.43	0.07	0.29	0.07
Diluted EPS	-0.11	-0.15	-7.56	-0.26	-0.11	3.26	-0.33	-0.06	0.43	0.07	0.29	0.07
Continuing & Discontinued Operations
+ Discontinued Operations — before Tax	0.0	0.0	0.0	-1.0	0.1	42.8	-5.2	0.0	6.9	0.0	0.0	0.0
+ Tax — Discontinued Operations	0.0	0.0	0.0	0.0	-0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	—	—	—	—	0.0	-0.0	0.1	0.0	0.0	—
+ Items NOT to be Reclassified to P&L	-0.1	-0.0	0.2	-0.0	0.1	-0.0	0.0	—	—	0.0	—	—
+ Tax on Items NOT to be Reclassified — alt tag	-0.0	-0.0	0.1	0.0	0.0	0.0	—	—	—	—	—	—
+ Items to be Reclassified to P&L	-0.0	-0.0	0.0	0.0	-0.0	-0.1	0.0	-0.0	0.1	—	—	—
Comprehensive Income — Owners of Parent	—	-2.1	0.2	-3.8	0.0	47.5	-4.8	-0.9	0.1	—	—	—
Comprehensive Income — Non-controlling Interests	—	0.0	-110.4	0.0	-1.5	0.0	0.0	0.0	6.3	—	—	—
Per Share — as-filed variants
Basic EPS — Continuing Operations	-0.11	-0.15	-7.56	-0.19	-0.11	0.33	0.02	-0.06	-0.04	0.07	0.29	0.07
Diluted EPS — Continuing Operations	-0.11	-0.15	-7.56	-0.19	-0.11	0.33	0.02	-0.06	-0.04	0.07	0.29	0.07
Basic EPS — Discontinued Operations	0.00	0.00	0.00	-0.07	0.00	2.93	-0.35	0.00	0.47	0.00	0.00	0.00
Diluted EPS — Discontinued Operations	0.00	0.00	0.00	-0.07	0.00	2.93	-0.35	0.00	0.47	0.00	0.00	0.00
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	12.1	10.9	9.0	—	—	—	—	—	—	—	-0.0	0.1
Gross Margin %	66.83	64.40	67.87	—	—	—	—	—	—	—	-0.03	0.35
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	-1.6	-1.0	-17.9	-2.7	-1.7	4.9	0.3	-0.9	-0.5	1.1	4.4	1.1
− Exceptional Items (reconciliation)	0.0	0.0	-92.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Net Income Adj (tax-effected)	-1.5	-2.1	-17.9	-3.7	-1.6	47.7	-4.9	-0.9	6.3	1.1	4.4	1.1
EPS Adj	-0.11	-0.15	-1.22	-0.26	-0.11	3.26	-0.33	-0.06	0.43	0.07	0.29	0.07
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00
Paid Up Equity Capital	14.6	14.6	14.6	14.6	14.6	14.6	14.6	14.6	14.6	14.8	14.8	14.8

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

TAKE quarterly results

TAKE (NSE: TAKE) has not yet announced the date of its Q2 FY27 results (July–September 2026); they are due by 14 November 2026 under SEBI's 45-day rule. Its latest results are for Q1 FY27 (April–June 2026). Consolidated net profit was ₹1.1 crore, against a loss of ₹91 lakh in Q1 FY26 and down 75.6% from ₹4.4 crore in Q4 FY26. Revenue from operations was ₹30.4 crore, down 43.9% from the previous quarter.

Q2 FY26 results (a year earlier): 27 October 2025
Q1 FY27 results (the latest): 11 August 2026

Latest results: Q1 FY27 (Apr–Jun 2026) · consolidated

Q2 FY27 results due by: 14 November 202645 days after the quarter (SEBI)
Q1 FY27 net profit: ₹1.1 Crloss ₹91 lakh in Q1 FY26−75.6% vs Q4 FY26
Q1 FY27 revenue: ₹30.4 Cr−43.9% vs Q4 FY26
Q1 FY27 operating margin: −0.9%+0.7 pts vs Q4 FY26
Q2 FY26 net profit (a year earlier): ₹6.3 Cr
Q1 FY27 EPS (basic): ₹0.07

Questions

When will TAKE announce its Q2 FY27 results?

The date is not announced yet. Results for July–September 2026 are due by 14 November 2026 (45 days after the quarter, SEBI Regulation 33). Last year it reported Q2 FY26 on 27 October 2025.

What were TAKE's Q1 FY27 results?

Consolidated net profit was ₹1.1 crore, against a loss of ₹91 lakh in Q1 FY26 and down 75.6% from ₹4.4 crore in Q4 FY26. Revenue from operations was ₹30.4 crore, down 43.9% from the previous quarter.

What was TAKE's net profit in FY26?

Consolidated net profit was ₹10.8 crore in FY26 (April 2025–March 2026), down 71.0% from ₹37.5 crore in FY25. It was a loss of ₹120 crore in FY24 and a loss of ₹100 crore in FY23.

What will TAKE's Q2 FY27 results be compared with?

With the same quarter a year earlier, Q2 FY26 (July–September 2025), when consolidated net profit was ₹6.3 crore. The latest quarter, Q1 FY27, had a net profit of ₹1.1 crore and revenue of ₹30.4 crore.

How has TAKE's profit changed over the last four quarters?

Net profit by quarter: ₹6.3 crore in Q2 FY26, ₹1.1 crore in Q3 FY26, ₹4.4 crore in Q4 FY26 and ₹1.1 crore in Q1 FY27. That is ₹12.8 crore over the four quarters, down 68.2% from ₹40.3 crore in the four quarters before.

What was TAKE's revenue in FY26?

Revenue from operations was ₹54.2 crore in FY26 (April 2025–March 2026). It was ₹65.6 crore in FY24 and ₹189 crore in FY23: down 71.3% over three years, an average fall of 34.1% a year.

Where do these TAKE figures come from?

From TAKE's own consolidated results filings to NSE, in ₹ crore as filed; the date from its board-meeting notices.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.